| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |